Adapted Treatment of Epstein-Barr Virus Infection to Prevent Posttransplant Lymphoproliferative Disorder After Heart Transplantation-Reference-Cited by-同舟云学术

Adapted Treatment of Epstein-Barr Virus Infection to Prevent Posttransplant Lymphoproliferative Disorder After Heart Transplantation

Author:

Choquet S.¹,Varnous S.²,Deback C.³,Golmard J. L.⁴,Leblond V.¹

Affiliation:

1. Clinical Hematology Unit; CHU La Pitié Salpêtrière Hospital, APHP; Paris France

2. Department of Heart Surgery; CHU La Pitié Salpêtrière Hospital, APHP; Paris France

3. Virology Laboratory; CHU La Pitié Salpêtrière Hospital, APHP; Paris France

4. Department of Biostatistics; CHU La Pitié Salpêtrière Hospital, APHP; Paris France

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference45 articles.

1. Malignant lymphomas in transplantation patients;Penn;Transplant Proc,1969

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Epstein-Barr Virus: Acute Infection, Oncogenesis, Prevention and Pitfalls;Global Virology IV: Viral Disease Diagnosis and Treatment Delivery in the 21st Century;2024